Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT01577550
First received: April 10, 2012
Last updated: October 26, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)